Looks very tightly held, top 20 own close to 90% of the stock...not much out there as a free float. If this thing hits paydirt, she'll fly....DYOR
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%